On October 8, WilmerHale Partner Mark Ford will participate in a panel during the first day of Informa’s Pharma Law USA 2024 conference. The two-day event aims to examine recent legal developments affecting pharma. Mr. Ford’s session, “How are the Courts Approaching Product Hopping?”, will address the legal standards that have developed for antitrust claims alleging so-called “product hops.” The panel will explore questions surrounding the topic, including:
- What are the issues at stake?
- How are the Courts approaching product hopping cases?
- Will the Supreme Court need to litigate to address the patchwork of approaches?
View the full agenda for the conference here.
